Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64045 participants
OBSERVATIONAL
2019-12-01
2020-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fractional Flow Reserve Fax Registry
NCT03055910
FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction
NCT02943954
Fractional Flow Reserve Versus Angiographically Guided Management to Optimise Outcomes in Unstable Coronary Syndromes
NCT01764334
Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography
NCT01233518
Outcomes With Fractional Flow Reserve in Chronic Coronary Syndrome
NCT05592535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Angiography + FFR
Patients were stratified into the FFR group if a coronary angiography with adjunctive FFR measurement was performed during the index hospitalization.
Fractional flow reserve
Patients were stratified into the FFR group if a coronary angiography with adjunctive FFR measurement was performed during the index hospitalization.
Angiography only
Patients were stratified into the angiography-only group if a coronary angiography without adjunctive FFR measurement was performed.
Angiography-only
Patients were stratified into the angiography-only group if a coronary angiography without adjunctive FFR measurement was performed.
Subgroup ACS
Patients were stratified by index diagnoses, i.e. acute coronary syndrome (ACS) or chronic coronary syndrome (CCS) according to the index hospital admission diagnosis.
This subgroup consists of patients presenting with ACS.
Fractional flow reserve
Patients were stratified into the FFR group if a coronary angiography with adjunctive FFR measurement was performed during the index hospitalization.
Angiography-only
Patients were stratified into the angiography-only group if a coronary angiography without adjunctive FFR measurement was performed.
Subgroup CCS
Patients were stratified by index diagnoses, i.e. acute coronary syndrome (ACS) or chronic coronary syndrome (CCS) according to the index hospital admission diagnosis.
This subgroup consists of patients presenting with CCS.
Fractional flow reserve
Patients were stratified into the FFR group if a coronary angiography with adjunctive FFR measurement was performed during the index hospitalization.
Angiography-only
Patients were stratified into the angiography-only group if a coronary angiography without adjunctive FFR measurement was performed.
Subgroup revascularization
Patients were stratified by the type of treatment, i.e. percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), or conservative management with optimal medical therapy (OMT) alone, based on the procedure codes during the index hospital stay.
This subgroup consists of patients undergoing revascularization after an angiography (with or without FFR) during the index hospital stay.
Fractional flow reserve
Patients were stratified into the FFR group if a coronary angiography with adjunctive FFR measurement was performed during the index hospitalization.
Angiography-only
Patients were stratified into the angiography-only group if a coronary angiography without adjunctive FFR measurement was performed.
Subgroup optimal medical therapy
Patients were stratified by the type of treatment, i.e. percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), or conservative management with optimal medical therapy (OMT) alone, based on the procedure codes during the index hospital stay.
This subgroup consists of patients undergoing optimal medical therapy after an angiography (with or without FFR) during the index hospital stay.
Fractional flow reserve
Patients were stratified into the FFR group if a coronary angiography with adjunctive FFR measurement was performed during the index hospitalization.
Angiography-only
Patients were stratified into the angiography-only group if a coronary angiography without adjunctive FFR measurement was performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fractional flow reserve
Patients were stratified into the FFR group if a coronary angiography with adjunctive FFR measurement was performed during the index hospitalization.
Angiography-only
Patients were stratified into the angiography-only group if a coronary angiography without adjunctive FFR measurement was performed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott
INDUSTRY
Charite University, Berlin, Germany
OTHER
University Hospital, Zürich
OTHER
University Hospital Schleswig-Holstein
OTHER
Ruhr University of Bochum
OTHER
LinkCare GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tobias Vogelmann, MSc
Role: STUDY_CHAIR
LinkCare GmbH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LinkCare GmbH
Stuttgart, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VF/1021/1084
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.